Castle Biosciences, Inc.
NASDAQ:CSTL
32.78 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 98.841 | 122.948 | 329.633 | 409.852 | 98.845 | 4.479 | 1.212 |
| Short Term Investments
| 144.258 | 135.677 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 243.099 | 258.625 | 329.633 | 409.852 | 98.845 | 4.479 | 1.212 |
| Net Receivables
| 38.302 | 23.476 | 17.282 | 12.759 | 14.648 | 12.09 | 4.652 |
| Inventory
| 7.942 | 3.98 | 2.021 | 2.217 | 1.237 | 0.882 | 0.305 |
| Other Current Assets
| 6.292 | 6.207 | 9.614 | 9.532 | 3.902 | 0.675 | 0.516 |
| Total Current Assets
| 295.635 | 292.288 | 353.743 | 429.594 | 116.681 | 18.126 | 6.684 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 37.739 | 26.496 | 16.884 | 7.102 | 2.06 | 1.529 | 1.47 |
| Goodwill
| 10.692 | 10.692 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 106.643 | 115.656 | 88.922 | 0 | 0 | 0.004 | 0.04 |
| Goodwill and Intangible Assets
| 117.335 | 126.348 | 88.922 | 0 | 0 | 0.004 | 0.04 |
| Long Term Investments
| 1.191 | 1.087 | 1.308 | 1.096 | 0.87 | 2.532 | 1.562 |
| Tax Assets
| 24.471 | 26.689 | -1.308 | 0 | 0 | -2.532 | -1.562 |
| Other Non-Current Assets
| 1.44 | -25.579 | 3.023 | 1.536 | 0.135 | 2.746 | 1.626 |
| Total Non-Current Assets
| 182.176 | 155.041 | 108.829 | 9.734 | 3.065 | 4.279 | 3.136 |
| Total Assets
| 477.811 | 447.329 | 462.572 | 439.328 | 119.746 | 22.405 | 9.82 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 10.268 | 4.731 | 2.546 | 2.098 | 1.865 | 1.451 | 1.117 |
| Short Term Debt
| 2.274 | 3.554 | 2.358 | 0 | 5.833 | 0 | 1.004 |
| Tax Payables
| 0 | 0.037 | 0.695 | 0.062 | 0.079 | 0.009 | 0.01 |
| Deferred Revenue
| 0 | 0 | 0 | 6.615 | 0 | 0 | 0.01 |
| Other Current Liabilities
| 35.125 | 27.806 | 19.287 | 12.101 | 7.512 | 5.277 | 3.081 |
| Total Current Liabilities
| 47.667 | 36.128 | 24.886 | 20.876 | 15.289 | 6.737 | 5.221 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 14.173 | 11.533 | 6.9 | 0 | 19.289 | 24.5 | 17.603 |
| Deferred Revenue Non-Current
| -0.025 | 0 | 0 | 1.735 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 24.677 | 0.428 | 0.635 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.025 | 0.09 | 18.411 | 1.026 | 0.055 | 1.237 | 1.268 |
| Total Non-Current Liabilities
| 38.875 | 12.051 | 25.946 | 2.761 | 19.344 | 25.737 | 18.871 |
| Total Liabilities
| 86.542 | 48.179 | 50.832 | 23.637 | 34.633 | 32.474 | 24.092 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 119.746 | 46.496 | 36.039 |
| Common Stock
| 0.027 | 0.027 | 0.025 | 0.025 | 0.017 | 0.002 | 0.002 |
| Retained Earnings
| -218.371 | -160.905 | -93.767 | -62.496 | -52.212 | -57.489 | -51.122 |
| Accumulated Other Comprehensive Income/Loss
| 0.136 | -0.381 | 0 | 0 | -119.746 | -0.909 | -0.638 |
| Other Total Stockholders Equity
| 609.477 | 560.409 | 505.482 | 478.162 | 257.054 | -2.093 | 0.638 |
| Total Shareholders Equity
| 391.269 | 399.15 | 411.74 | 415.691 | 85.113 | -10.069 | -14.271 |
| Total Equity
| 391.269 | 399.15 | 411.74 | 415.691 | 85.113 | -10.069 | -14.271 |
| Total Liabilities & Shareholders Equity
| 477.811 | 447.329 | 462.572 | 439.328 | 119.746 | 22.405 | 9.82 |